Diagnostic and
G OALS
Screening Tests Test properties: sensitivity,
specificity, predictive value,
Stephen McCurdy, M.D., M.P.H.
likelihood ratio, validity, precision
Division of Environmental and Occupational Health Fundamentals of screening
Department of Public Health Sciences Parallel and serial testing
U.C. Davis School of Medicine
Yet--
Yet--no
no test is infallible. . . () C D C+D (all
(FN) (TN) negatives)
We may see false positive and false
negative results. Total A+C B+D A+B+C+D
(All ill) (All (Grand Total)
healthy)
() C D C+D () C D C+D
(FN) (TN)
(True) prevalence: Proportion of persons with disease in Sensitivity: Likelihood a diseased person will have a
the population. Prevalence = (A+C)/(A+B+C+D) positive test Sensitivity = TP/All disease = A/(A+C)
Of 1000 kids, 78 have head lice. Prevalence = 7.8% Of 100 men with prostate Ca, 90 have (+) PSA.
Sensitivity=90%
1
Diagnostic and Screening Tests Diagnostic and Screening Tests
Test properties DISEASE
(+) () Total
There is a yin-
yin-yang relationship
(+) A B A+B between sensitivity and specificity.
TEST (TP) (FP)
Changing test cut-
cut-off values to
() C D C+D increase the sensitivity will reduce
(FN) (TN)
the specificity, and vice-
vice-versa.
Total A+C B+D A+B+C+D
Specificity: Likelihood a healthy person will have a
negative test Specificity = TN/All healthy = D/(B+D)
() C D C+D () C D C+D
2
Diagnostic and Screening Tests Diagnostic and Screening Tests
DISEASE
Consider: What is the likelihood that a (+) () Total
person with a positive test will Sens x 2000 Population: 10,000
(+) Prevalence: 20%
actually have the disease (i.e., what TEST
1800 800 2600
Sensitivity: 90%
is the PV+) when. . . ()
Spec x 8000
Specificity:90%
200 7200 7400
Prevalence=20% in a population of 104
Total 2000 8000 10,000
Sensitivity=90%
Specificity=90% PV(+)=TP/All Positives=1800/2600=69.2%
Conclude: Only 69.2% of persons with a positive
test actually have the disease. (Tests aint perfect!)
LR= Likelihood of (+) test in diseased persons High transferrin in anemic patients: 90%
Likelihood of (+) test in healthy persons High transferrin in healthy, nonanemic patients:
15%
3
Diagnostic and Screening Tests
The take-
take-home message: Although a positive test 1
result identifies a group with increased 0.9
prevalence of the disease, the prevalence may 0.8 Test=(+) X
still be very low when you are starting with a rare 0.7
disease. 0.6
Implication: Don
Dont do cardiac stress tests on 0.5
marathon runners! Any positive is likely to be a 0.4 X
false positive. 0.3
0.2 Test=(-)
Tests should be limited to situations in which there
is some intermediate probability of disease, 0.1 X
where the result will affect your approach. (See 0
following slide.) 0 0.2 0.4 0.6 0.8 1
Pre-test Probability
4
Diagnostic and Screening Tests
G OALS
Test properties: sensitivity,
specificity, predictive value,
likelihood ratio, validity, precision
Fundamentals of screening
Parallel and serial testing